FDA inspection
Nordson Medical Design and Development, Inc.: FDA inspection ending Oct 31, 2023
FDA inspection 1221592 · Official Action Indicated (OAI) · San Jose, CA
Key facts
| Inspection ID | 1221592 |
|---|---|
| Firm | Nordson Medical Design and Development, Inc. |
| FEI number | 3017033740 |
| Address | 105 E Tasman Dr |
| City | San Jose |
| State | CA |
| ZIP | 95134-1616 |
| Fiscal year | 2024 |
| Inspection end date | Oct 31, 2023 |
| Classification | Official Action Indicated (OAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data